BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Safic Stanic H, Babic I, Maslovic M, Dogic V, Bingulac-Popovic J, Miletic M, Jurakovic-Loncar N, Vuk T, Strauss-Patko M, Jukic I. Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia. Transfus Med Hemother 2017;44:415-20. [PMID: 29344018 DOI: 10.1159/000457965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Blood Transfus 2019;17:403-8. [PMID: 31846605 DOI: 10.2450/2019.0182-19] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Candotti D, Laperche S. Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures? Front Med (Lausanne) 2018;5:29. [PMID: 29515997 DOI: 10.3389/fmed.2018.00029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
4 Li W, Gao Z, Yang C, Li J, Li L, Lv R, Liu Z. The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011. PLoS One 2013;8:e73472. [PMID: 24058476 DOI: 10.1371/journal.pone.0073472] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013;13:e6590. [PMID: 23675384 DOI: 10.5812/hepatmon.6590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
6 Lindenberg Ade S, Motta-Castro AR, Puga MA, Ortiz Tanaka TS, Torres MS, Fernandes-Fitts SM, Cunha RV. Decrease in hepatitis B prevalence among blood donors in Central-West Brazil. J Venom Anim Toxins Incl Trop Dis 2013;19:7. [PMID: 23849137 DOI: 10.1186/1678-9199-19-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
7 Li L, Han T, Zang L, Niu L, Cheng W, Lin H, Li KY, Cao R, Zhao B, Liu Y, Ou G, Liu X, Qi Y, Li Y, Liu Z. The current incidence, prevalence, and residual risk of hepatitis B viral infections among voluntary blood donors in China. BMC Infect Dis 2017;17:754. [PMID: 29212443 DOI: 10.1186/s12879-017-2861-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]